We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
- Authors
Andriole, Gerald L; Crawford, E David; Grubb, Robert L, 3rd; Buys, Saundra S; Chia, David; Church, Timothy R; Fouad, Mona N; Isaacs, Claudine; Kvale, Paul A; Reding, Douglas J; Weissfeld, Joel L; Yokochi, Lance A; O'Brien, Barbara; Ragard, Lawrence R; Clapp, Jonathan D; Rathmell, Joshua M; Riley, Thomas L; Hsing, Ann W; Izmirlian, Grant; Pinsky, Paul F; Kramer, Barnett S; Miller, Anthony B; Gohagan, John K; Prorok, Philip C; PLCO Project Team
- Abstract
The prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was undertaken to determine whether there is a reduction in prostate cancer mortality from screening using serum prostate-specific antigen (PSA) testing and digital rectal examination (DRE). Mortality after 7-10 years of follow-up has been reported previously. We report extended follow-up to 13 years after the trial.
- Publication
Journal of the National Cancer Institute, 2012, Vol 104, Issue 2, p125
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/djr500